Lv41
470 积分 2025-10-15 加入
Validation of the GALAD model for early diagnosis and monitoring of hepatocellular carcinoma in Chinese multicenter study
1分钟前
待确认
Value of autotaxin for hepatocellular carcinoma risk assessment in chronic hepatitis B patients treated with nucleos(t)ide analogs
6分钟前
待确认
Five‐year on‐treatment variables‐based PPACS model predicts subsequent hepatocellular carcinoma in entecavir/tenofovir‐treated patients
16分钟前
已完结
A Machine Learning Model to Predict De Novo Hepatocellular Carcinoma Beyond Year 5 of Antiviral Therapy in Patients With Chronic Hepatitis B
22分钟前
已完结
PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B
1小时前
已完结
Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis B
1小时前
已完结
Predictive Performance of CAGE-B and SAGE-B Models in Asian Treatment-Naive Patients Who Started Entecavir for Chronic Hepatitis B
1小时前
已完结
Risk predictive model for the development of hepatocellular carcinoma before initiating long‐term antiviral therapy in patients with chronic hepatitis B virus infection
1小时前
已完结
MR elastography-based prediction of development of hepatocellular carcinoma in patients with chronic hepatitis B with sustained virological response
1小时前
已完结
Performance of the GALAD Model in an Asian Cohort Undergoing Hepatocellular Carcinoma Surveillance: A Prospective Cohort Study
11天前
已完结
皖公网安备34019202002308
